Statistical flag only — not an accusation of fraud
⚠️ This provider averages 539 services per working day — physically unusual for an individual practitioner
Based on 1.3M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $18.0M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 539 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 499% from 2014 to 2023.
This provider has been statistically flagged with a risk score of 66/100. Statistical flags are not accusations of fraud.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 276% in 2015
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $50.16 | $16.40 | 3.06x | $33.76 | $536.1K | 32.7K | 32 |
| 2015 | $60.51 | $20.12 | 3.01x | $40.39 | $2.0M | 100.2K | 42 |
| 2016 | $48.31 | $17.03 | 2.84x | $31.28 | $860.2K | 50.5K | 33 |
| 2017 | $35.69 | $10.86 | 3.29x | $24.83 | $862.9K | 79.5K | 34 |
| 2018 | $43.39 | $12.95 | 3.35x | $30.44 | $1.4M | 107.0K | 39 |
| 2019 | $28.87 | $8.48 | 3.40x | $20.39 | $1.3M | 155.5K | 46 |
| 2020 | $33.91 | $9.50 | 3.57x | $24.41 | $1.5M | 157.5K | 42 |
| 2021 | $51.40 | $11.89 | 4.32x | $39.51 | $3.0M | 253.7K | 44 |
| 2022 | $69.14 | $14.93 | 4.63x | $54.21 | $3.3M | 222.1K | 50 |
| 2023 | $71.89 | $17.07 | 4.21x | $54.82 | $3.2M | 188.2K | 45 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 115.0K | $4.8M | $42.04 | 3.32x |
| J0897 | Injection, denosumab, 1 mg | 143.9K | $2.2M | $15.05 | 3.31x |
| J9299 | Injection, nivolumab, 1 mg | 66.2K | $1.3M | $18.97 | 3.89x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 13.4K | $1.1M | $82.25 | 2.57x |
| J2505 | Injection, pegfilgrastim, 6 mg | 315 | $971.3K | $3.1K | 2.93x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 6.5K | $642.2K | $98.23 | 4.69x |
| J9119 | Injection, cemiplimab-rwlc, 1 mg | 25.9K | $549.0K | $21.20 | 3.52x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 9.2K | $501.6K | $54.59 | 2.77x |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 5.8K | $453.2K | $78.72 | 2.72x |
| J9310 | Injection, rituximab, 100 mg | 713 | $404.7K | $567.59 | 2.36x |
| J9035 | Injection, bevacizumab, 10 mg | 6.7K | $358.7K | $53.94 | 2.37x |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 9.3K | $290.6K | $31.24 | 5.97x |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 1.8K | $260.9K | $148.42 | 2.73x |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | 2.2K | $254.4K | $116.68 | 2.49x |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 343.7K | $252.6K | $0.73 | 5.54x |
| Q5120 | Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg | 1.3K | $242.3K | $192.28 | 4.59x |
| Q5111 | Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg | 780 | $216.6K | $277.66 | 3.23x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 18.7K | $166.9K | $8.92 | 3.91x |
| J9355 | Injection, trastuzumab, 10 mg | 2.2K | $146.2K | $67.17 | 2.38x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 15.1K | $145.1K | $9.58 | 4.21x |
This provider submits charges 3.85 times higher than what Medicare actually pays.
A markup ratio of 3.85x means for every $100 Medicare pays, this provider initially charges $385. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in IN for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Mohamad Kassar, M.D. | Dyer, IN | $40.6M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data